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a b s t r a c t
Hypoxia in the tumor microenvironment triggers differential signaling pathways for tumor survival. In this
study, we characterize the involvement of hypoxia and reactive oxygen species (ROS) generation in the
antineoplastic mechanism of proopiomelanocortin (POMC) gene delivery in a mouse B16-F10 melanoma
model in vivo and in vitro. Histological analysis revealed increased TUNEL-positive cells and enhanced
hypoxic activities in melanoma treated with adenovirus encoding POMC (Ad-POMC) but not control vector.
Because the apoptotic cells were detected mainly in regions distant from blood vessels, it was
hypothesized that POMC therapy might render melanoma cells vulnerable to hypoxic insult. Using a
hypoxic chamber or cobalt chloride (CoCl2), we showed that POMC gene delivery elicited apoptosis and
caspase-3 activation in cultured B16-F10 cells only under hypoxic conditions. The apoptosis induced by
POMC gene delivery was associated with elevated ROS generation in vitro and in vivo. Blocking ROS
generation using the antioxidant N-acetyl-L-cysteine abolished the apoptosis and caspase-3 activities
induced by POMC gene delivery and hypoxia. We further showed that POMC-derived melanocortins,
including α-MSH, β-MSH, and ACTH, but not γ-MSH, contributed to POMC-induced apoptosis and ROS
generation during hypoxia. To elucidate the source of ROS generation, application of the NADPH oxidase
inhibitor diphenyleneiodonium attenuated α-MSH-induced apoptosis and ROS generation, implicating the
proapoptotic role of NADPH oxidase in POMC action. Of the NADPH oxidase isoforms, only Nox4 was
expressed in B16-F10 cells, and Nox4 was also elevated in Ad-POMC-treated melanoma tissues. Silencing
Nox4 gene expression with Nox4 siRNA suppressed the stimulatory effect of α-MSH-induced ROS
generation and cell apoptosis during hypoxia. In summary, we demonstrate that POMC gene delivery
suppressed melanoma growth by inducing apoptosis, which was at least partly dependent on Nox4
upregulation.
& 2013 The Authors. Published by Elsevier Inc.
Hypoxia plays a critical role in cancer development and
progression. Low oxygen concentrations in the tumor microenvir-
onment facilitate recruitment of vascular endothelial cells and
promote angiogenesis to supply oxygen and nutrients to tumor
cells. To adapt metabolically to hypoxic conditions, tumor cells also
exhibit increased glucose transport and anaerobic glycolysis [1].
Fifty to sixty percent of locally advanced solid tumors, including
melanomas, are characterized by areas of hypoxia/anoxia that
result from an imbalance between oxygen supply and consump-
tion in proliferating tumor cells. This imbalance is further exacer-
bated by a compromised tumor vasculature [2]. Studies have
shown that the presence of hypoxia within a tumor is an
independent marker of a poor prognosis for patients with various
cancer types including cutaneous melanomas [3]. Because strin-
gent hypoxia/anoxia (o0.5% O2) is toxic for normal and tumor
cells, it can promote tumor progression by selecting cells with
mutations that allow them to survive under these extreme condi-
tions [4]. Furthermore, hypoxia activates signaling pathways that
trigger neovascularization and facilitates tumor cell invasion,
migration, adhesion, and metastasis [5].
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Reactive oxygen species (ROS) are oxygen-containing, short-
lived molecules that are highly reactive. The most common
examples include superoxide, hydrogen peroxide (H2O2), hydroxyl
radical (dOH), nitric oxide (NO), and peroxynitrite (ONOO). ROS
are generally considered unwanted by-products produced from
aerobic metabolism; for instance, superoxide is produced during
mitochondrial oxidative phosphorylation [6]. Various enzyme
systems produce ROS, including the mitochondrial electron trans-
port chain, cytochrome P450, lipooxygenase, cyclooxygenase,
NADPH oxidase complex, xanthine oxidase, and peroxisomes [7].
ROS are increased in malignant cells in part as a result of oncogene
signaling via the NADPH oxidase complex and by hypoxia-related
mitochondrial ROS. Increased oxidant levels contribute to
enhanced cell proliferation and suppression of apoptosis. Oxygen
depletion stimulates mitochondria to produce ROS [8], which
activate signaling pathways involving hypoxia-inducible factor
1α, which in turn promote cancer cell survival and tumor growth
[9,10]. However, an overproduction of ROS can cause apoptosis by
opening the mitochondrial permeability transition pore and thus
releasing proapoptotic factors [11,12]. How cancer cells manage
the balance of ROS during cancer development still remains
unclear.
Proopiomelanocortin (POMC) is a stress hormone and is pro-
cessed into various neuropeptides including adrenocorticotrophic
hormone (ACTH); α-, β-, and γ-melanocyte-stimulating hormone
(MSH); and β-endorphin through POMC-processing enzymes such
as prohormone convertases 1 and 2. POMC-derived peptides
possess pleiotropic functions, including pigmentation, adrenocor-
tical function, regulation of energy homeostasis, and immunity
modulation, in the central and peripheral systems [13–16].
A POMC-derived peptide, α-MSH, has been reported to trigger
melanoma and melanocyte differentiation [17] and potently inhi-
bits migration and invasion of B16-BL6 melanoma cells in vitro
and in vivo [18]. These ﬁndings suggest that POMC expression may
inhibit the tumorigenicity of tumors.
We and others recently showed that targeted gene therapy
with POMC suppressed the growth of melanoma and lung cancer
in animals [19–21]. In this study, we therefore characterized the
tumor-suppressive mechanisms of POMC in a mouse model of
melanoma in vivo and in vitro, by overexpressing POMC using
adenoviruses carrying the POMC gene. We ﬁrst characterized the
effects of POMC overexpression on cell apoptosis and then
explored how POMC overexpression caused apoptosis under
hypoxia. We identiﬁed a novel tumor-suppressive mechanism of
POMC that facilitates cell apoptosis through modulation of the
ROS-inducing enzyme NADPH oxidase 4 (Nox4) in melanoma.
POMC gene delivery may represent a novel therapeutic avenue for
the treatment of melanoma.
Materials and methods
Preparation of adenovirus vectors
To overexpress POMC in B16-F10 melanoma cells, cells were
infected with recombinant adenoviruses containing the POMC gene
(Ad-POMC) or control green ﬂuorescent protein (Ad-GFP). Ad-GFP
and Ad-POMC were generated as previously described [22].
Primary melanoma models and gene delivery
All animal experiments were carried out under protocols
approved by the Institutional Animal Care and Use Committee
of National Sun Yet-Sen University. To induce the primary mela-
noma, B16-F10 cells were subcutaneously injected into C57BL/6
mice (5105 cells in 0.1 ml of phosphate-buffered saline (PBS);
n¼13–15) to monitor tumor growth. After tumors had grown to at
least 100 mm3 (10 days after implantation), the mice were
administered adenoviral vector at the indicated doses in 0.1 ml
of PBS via intratumoral injection. Subsequently, tumor volumes
were measured with a dial-caliper according to the following
formula: width2 length0.52. For tumor-suppressing studies,
experiments were terminated when the tumor burden exceeded
10% of the animal’s normal body weight.
Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end
labeling (TUNEL) assay
B16-F10 melanoma cells were implanted at day 0 and treated
with intravenous injection of adenovirus vectors at day 10. After
treatment for 21 days, cell death in frozen mouse melanoma
sections was detected by enzyme labeling of DNA strand breaks
using a TUNEL assay (In Situ Cell Death Detection Kit; Roche, Basel,
Switzerland) according to the manufacturer0s instructions. Brieﬂy,
sections were incubated with a mixture of TdT and ﬂuorescein–
dUTP to react at 37 1C to label free 30-OH ends of genomic DNA.
After TUNEL staining, the sections were counterstained with
propidium iodide (PI; 500 ng/ml) for 30 min at 25 1C and viewed
under a ﬂuorescence microscope. For quantifying the immunos-
taining of TUNEL, each sample was randomly captured by micro-
scopy for at least ﬁve independent ﬁelds. An apoptotic index was
estimated by normalizing the number of TUNEL-positive cells to
the total number of PI-positive cells and calculated from ﬁve
independent ﬁelds with a 40 microscopic ﬁeld.
In situ detection of hypoxia
Cells undergoing hypoxia and apoptosis in mouse tumor tissue
sections were detected using pimonidazole (Hypoxyprobe-1;
Hypoxyprobe, Burlington, MA, USA) and a TUNEL kit according
to the manufacturer’s instructions. Sections were then counter-
stained with DAPI.
Cell cultures and reagents
Mouse (B16-F10) and human (A375 and A2058) melanoma
cells, mouse ﬁbroblast cells (NIH3T3), and rat hepatocytes (clone 9)
were purchased from the American Type Culture Collection
(Manassas, VA, USA) and cultured and maintained in complete
medium made up of Dulbecco’s modiﬁed Eagle’s medium
(Invitrogen, Carlsbad, CA, USA) with 10% fetal bovine serum
(FBS; Hyclone, Logan, UT, USA), 2 mM glutamine, 100 mg/ml
streptomycin (Invitrogen), and 100 U/ml penicillin, at 37 1C in a
5% CO2 atmosphere. ACTH, α-MSH, β-MSH, and γ-MSH were
purchased from Bachem (Torrance, CA, USA). Cobalt chloride
(CoCl2), diphenyleneiodonium chloride (DPI), rotenone, allopuri-
nol, 20,70-dichlorodihydroﬂuorescein diacetate (DCFH-DA), dihy-
droethidium (DHE), N-acetyl-L-cysteine (NAC), and indomethacin
were purchased from Sigma–Aldrich (St. Louis, MO, USA).
Treatment of hypoxia
To mimic hypoxic conditions, cells were incubated in a com-
mercially available hypoxia system (o1% oxygen), GENbox Jar
(BioMerieux), used as previously described [23], or treated with a
pharmacological agent, CoCl2 (100 μM), at 37 1C. The duration of
hypoxia treatment was between 48 and 72 h depending on
experimental conditions as described below.
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Cell cycle analysis
B16-F10 cells were infected with Ad-POMC and Ad-GFP at a
multiplicity of infection (m.o.i.) of 1000 for 48 h. After infection,
the cells were maintained in complete medium with reduced FBS
(1%) for hypoxia treatments. Cells were harvested, washed twice
with PBS before ﬁxation with ice-cold ethanol (70%), and then
stored overnight at 20 1C. Cells were washed twice with PBS
before incubation with RNase A (10 mg/ml) and PI (50 mg/ml) for
30 min at 37 1C. The DNA content of 20,000 events was analyzed
using a FACSCalibur ﬂow cytometer (Becton Dickinson Bios-
ciences; San Jose, CA, USA) and CELLQuest software.
Measurement of ROS generation by 20,70-dichloroﬂuorescein diacetate
(DCF-DA)
Intracellular ROS concentration was measured using DCF-DA as
previously described [24]. For gene delivery, cells (1105 cells/
well) were seeded in six-well plates and subjected to infection
with adenovirus vectors at an m.o.i. of 1000 for 24 h and hypoxia
treatment for another 24 h before DCF-DA. For peptide treatment,
B16-F10 cells (1105 cells/well) were seeded in six-well plates
and pretreated with ACTH, α-MSH, β-MSH, and γ-MSH (10 nM) for
24 h and then incubated with CoCl2 (100 μM) for another 24 h
before DCF-DA. Cells were rinsed with HBSS (Hanks’ balanced salt
solution), loaded with DCF-DA (10 μM), and incubated for 15 min
at 37 1C. DCF ﬂuorescent signals were detected immediately by
FACSCalibur ﬂow cytometer (Becton Dickinson Biosciences) and
CELLQuest software.
Hydrogen peroxide measurement by Amplex red
Extracellular H2O2 was detected using Amplex red assay as
previously described [24]. For gene delivery, cells (1105 cells/
well) were seeded in six-well plates and subjected to infection
with adenovirus vectors at an m.o.i. of 1000 for 24 h and hypoxia
treatment for another 24 h before Amplex red assay. For peptide
treatment, cells (1105 cells/well) were seeded in six-well plates
and pretreated with ACTH, α-MSH, β-MSH, and γ-MSH (10 nM) for
24 h and then incubated with CoCl2 (100 mM) for another 24 h
before Amplex red assay. After treatment, cells were suspended in
Krebs–Hepes buffer (HBSS, 98 mM NaCl, 4.7 mM KCl, 25 mM
NaHCO3, 1.2 mM MgSO4, 1.2 mM KH2PO4, 2.5 mM CaCl2, 11.1 mM
D-glucose, and 20 mM Hepes–Na) containing Amplex red reagent
(Invitrogen). Fluorescence was then measured with excitation and
emission at 480 and 530 nm, respectively, using a Polarstar
microplate reader (BMG Labtech) at 37 1C.
In situ superoxide detection
The superoxide in frozen tumor sections was detected by DHE
(5 μM) as previously described [25]. Brieﬂy, after TUNEL staining,
the sections were incubated with DHE for 30 min at 37 1C in a
humidiﬁed chamber protected from light. The red ﬂuorescence
was detected using a ﬂuorescence microscope (DP70; Olympus,
Tokyo, Japan).
Caspase-3 activity assay
Caspase-3 activity was measured using the CaspACE Assay
System, colorimetric kit (Promega, Madison, WI, USA). Brieﬂy,
cells (2105 cells/well) were seeded in a six-well tissue culture
plate (Falcon, Franklin Lakes, NJ, USA). After an infection with
adenovirus vectors at an m.o.i. of 1000 for 24 h, cells were
incubated with CoCl2 (100 μM) and in the absence or presence
of NAC (10 mM) in 1% FBS medium for 24 h. The lysate (100 μg)
was added to the CaspACE assay buffer containing the caspase-3
substrate Ac-DEVD-p-nitroaniline and incubated for 4 h at 37 1C.
Cells treated with dimethyl sulfoxide were used as controls.
Absorbance at 405 nm was read by a scanning multiwell spectro-
photometer (Dynatech Laboratories, Chantilly, VA, USA).
Western blot
Cell lysates were prepared and protein expression was mea-
sured as previously described [22]. The PVD membrane was
blocked with 5% milk in Tris-buffered saline–Tween 20 for 1 h
and then incubated with speciﬁc primary antibodies against Nox4
(1:500 dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA)
and β-actin antibodies (1:10,000 dilution; Sigma) for 1 h at room
temperature. After incubation with secondary antibody conjugated
with horseradish peroxidase (HRP; 1:10,000 dilution in 5% milk)
for 1 h, signals on the membrane were detected using chemilu-
minescent HRP substrate (Millipore Corp.; Billerica, MA, USA) and
exposed to X-ray ﬁlm for autoradiograms.
Quantitative real-time PCR
RNA was isolated from B16-F10 cells using RNAzol according to
the manufacturer’s instructions (Tel-Test, Friendswood, TX, USA).
Two micrograms of total RNA was used for reverse transcription
with SuperScript III (Invitrogen) using olio(dT) and random primers.
For quantitative real-time PCR, reactions were performed in an ABI
Prism 7700 system (Applied Biosystems, Foster City, CA, USA) using
the SYBR Green PCR master mix and the predesigned gene-speciﬁc
probe and primer sets for mouse Nox4 (NM_015760.4). Data were
normalized to β-actin (NM_007393.3) and expressed as fold
changes over that in the control experiments. The primer sequences
were as follows: Nox4 forward primer, 50-CTCAACTGCAGCCT-
CATCCTT-30, and reverse primer, 50-ACTGAAAAGTTGAGGGCATT-
CAC-30; β-actin forward primer, 50-GGAATCCTGTGGCATCCAT-30,
and reverse primer, 50-GCTCAGGAGGAGCAATGAT-30.
RNA interference
To knock down the gene expression of Nox4 we purchased
small interfering RNA (siRNA) from Santa Cruz Biotechnology. Cells
were transfected for 4 h and then incubated with complete
medium for 48 h. After transfection, the cells were pretreated
with CoCl2 for 1 h before treatment with and without α-MSH
(10 nM) for 24 h before cell harvest.
Statistical analysis
Data are presented as the mean7standard error of the mean
(SEM). The mean data were analyzed with one-way analysis of
variance followed by Newman–Keuls post hoc or t test (for multi-
ple comparisons). A p value of less than 0.05 was regarded as
statistically signiﬁcant.
Results
POMC gene delivery induces apoptosis in melanoma
To evaluate the therapeutic potential of POMC gene delivery,
mice bearing established melanoma were administered adenoviral
vector and then monitored for tumor progression. Mice treated
with Ad-POMC showed signiﬁcantly retarded melanoma growth
compared with control animals (Supplementary Fig. 1). To inves-
tigate the mechanism of POMC gene delivery on inhibition of
tumor growth, tumor tissues were collected and subjected to
G.-S. Liu et al. / Free Radical Biology and Medicine 70 (2014) 14–2216
histological analysis. Fluorescence images in Fig. 1A demonstrate
an accumulation of TUNEL-positive cells in tumor nodules sur-
rounding blood vessels in Ad-POMC-infected tumors, whereas few
apoptotic cells were found in Ad-GFP-infected melanoma. Quanti-
ﬁcation analysis of apoptotic events conﬁrmed that the apoptotic
index in Ad-POMC-infected melanoma was signiﬁcantly higher
than that in Ad-GFP-infected tumors (Fig. 1B).
POMC gene delivery induces apoptosis in melanoma cells under
a hypoxic challenge
Because TUNEL-positive apoptotic cells were detected predo-
minantly in the ischemic region distant from blood vessels, POMC
gene therapy seems to render melanoma cells susceptible to
hypoxic challenge. To address this aim, the extent of hypoxia in
tumor sections was detected with immunoﬂuorescence micro-
scopy using a conventional Hypoxyprobe-1 kit. Ad-POMC-infected
tumor sections demonstrated a greater degree of hypoxia in
comparison to Ad-GFP-infected tissues (Fig. 1C). To examine
whether cells undergoing apoptosis correlate with tissue hypoxia,
tumor sections were costained with TUNEL and Hypoxyprobe-1
probe. It was found that ischemic activity was localized in close
proximity to TUNEL-positive cells in Ad-POMC-infected tumors.
Although there was little hypoxic or TUNEL-positive signal in
Ad-GFP tumors, the distribution patterns of both signals were
similar to those of Ad-POMC-infected tumors, suggesting that
induction of apoptosis tends to occur in hypoxic regions.
Having established that the induction of cell apoptosis by
systemic POMC gene delivery was associated with tissue hypoxia,
we explored the mechanism underlying such process in B16-F10
melanoma cells. We used a hypoxia chamber (o1% oxygen) and a
pharmacological agent, CoCl2 (100 μM), to mimic hypoxic condi-
tions. Flow cytometry analysis demonstrated that the proportion
of apoptotic cells was increased about 12% in the Ad-POMC-
infected group in a hypoxia chamber (Fig. 2A). Cells treated with
CoCl2 analyzed by ﬂow cytometry analysis also showed an increase
in apoptotic cells in the Ad-POMC group compared to the Ad-GFP
group (Fig. 2B). The stimulatory effect of POMC gene delivery on
apoptosis in B16-F10 cells was further conﬁrmed by evaluating the
caspase-3 activity. As shown in Fig. 2C, Ad-POMC induced an
increase in caspase-3 activity in CoCl2-induced hypoxia. Taken
together, these results suggested that POMC gene delivery triggers
melanoma cells toward programmed cell death under hypoxic
challenges.
Melanocortins promote apoptosis of melanoma cells under hypoxia
Our previous study demonstrated that POMC-derived peptides
(α-MSH, β-MSH, and ACTH) reduced colony formation and inva-
sive potential in B16-F10 melanoma cells [19]. In this study, we
characterize which POMC-derived peptides induced apoptosis in
B16-F10 melanoma cells. To address this aim, cells were treated
with 10 nM α-MSH, β-MSH, ACTH, and γ-MSH under CoCl2-
induced hypoxic conditions. In ﬂow cytometry analysis, α-MSH,
β-MSH, and ACTH peptides enhanced the G0/G1-phase population
through a reduction in cell numbers in S and M phases in
normoxia, indicating cell cycle arrest (Supplementary Table 1).
However, under hypoxia conditions, α-MSH, β-MSH, and ACTH
peptides remarkably induced about 12% of the population of
apoptotic cells in pre-G0 phase, whereas γ-MSH had no such
effect (Fig. 3). A similar effect was observed in two human
melanoma cell lines (A375 and A2058), but not in two nontrans-
formed cell lines (NIH3T3 and clone 9) (Supplementary Fig. 2).
Therefore, we identiﬁed that α-MSH, β-MSH, and ACTH but not
γ-MSH induced apoptosis in melanoma cells during hypoxia,
which shows selectivity on melanoma cells.
Excessive ROS generation participated in POMC-induced apoptosis
during hypoxia
Having established that POMC overexpression potentiated the
effect of hypoxia on apoptosis of melanoma cells, we investigated
the molecular mechanisms underlying such process. ROS have
been implicated in the regulation of apoptosis in melanoma cells
[26,27]. We therefore performed in situ detection of superoxide
with DHE and TUNEL assay to assess the distribution of ROS
production and cell apoptosis in Ad-POMC- and Ad-GFP-treated
melanoma tissues. There was an accumulation of DHE ﬂuores-
cence distant from the blood vessel to the far tumor region and
such signal was colocalized with TUNEL-positive staining cells in
the Ad-POMC-treated group (Fig. 4A). Little DHE ﬂuorescence was
detected in Ad-GFP-treated melanoma tissues, suggesting that ROS
generation is associated with cell apoptosis in melanoma (Fig. 4A).
To elucidate a role for ROS generation in POMC-mediated cell
Fig. 1. Effect of systemic POMC overexpression on apoptosis in melanoma tissue. (A) The representative proﬁles of TUNEL staining in Ad-GFP- and Ad-POMC-treated
melanoma. Apoptotic cells in melanoma were detected by TUNEL staining (green) and the cell nucleus was counterstained with propidium iodide (PI; red). (B) Quantiﬁcation
of apoptotic index in Ad-POMC- and Ad-GFP-treated melanoma. The apoptotic index is expressed as the ratio of the number of TUNEL-positive cells to the number of
PI-positive cells. Data are expressed as mean7SEM from 6 experiments. (C) Correlation of apoptosis and hypoxia in melanoma. Hypoxia activity and apoptosis in melanoma
tissues were detected by the Hypoxyprobe-1 kit (pimonidazole; green) and TUNEL (red) assay, respectively, followed by counterstaining with DAPI (blue). Arrows indicate
hypoxic cells. Scale bar, 20 mm. npo0.05.
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apoptosis under hypoxia, we ﬁrst examined the effect of POMC
overexpression on ROS generation in B16-F10 melanoma cells under
normal and CoCl2-induced hypoxic conditions. Hypoxia increased
total ROS production detected by DCF-DA in control and Ad-GFP
infected cells, which was potentiated by an overexpression of POMC
in melanoma cells infected with Ad-POMC (Fig. 4B). There was a
tendency of increased H2O2 generation in hypoxic cells and such
increase was potentiated by Ad-POMC treatment (Fig. 4C). Moreover,
inhibition of ROS production with an antioxidant, NAC (10 mM),
was found to abrogate the Ad-POMC-stimulated augmentation of
caspase-3 activity and also rescued the Ad-POMC-induced apoptosis
comparisonwith the Ad-GFP group during hypoxia (Figs. 4D and 4E),
indicating that ROS production contributed to Ad-POMC-induced
apoptosis. In summary, our results suggested that ROS production
by POMC gene delivery was involved in apoptosis in melanoma
cells during hypoxia.
Fig. 2. Effect of POMC expression on sensitivity of melanoma cells to hypoxia. (A) Flow cytometry analysis of cells obtained from pre-G0 phase shows that Ad-POMC gene
delivery increased apoptotic cells compared to the Ad-GFP group in the hypoxia chamber. (B) Effect of hypoxia mimetic CoCl2 on cell apoptosis. (C) POMC gene delivery
triggered caspase-3 cascade activation in B16-F10 melanoma cells during hypoxia. The ratio of caspase-3 activity was measured by colorimetric caspase-3 activation assay.
Data are expressed as means7SEM from triplicate experiments. nnpo0.01.
Fig. 3. The effect of POMC-derived peptides on sensitivity of melanoma cells to hypoxia. Representative ﬂow cytometry demonstrating the effects of α-MSH, β-MSH, ACTH,
and γ-MSH neuropeptides (10 nM for each peptide) on cell populations under normal and CoCl2-induced hypoxic conditions. The percentage of apoptotic cells is expressed as
means7SEM from triplicate experiments. nnpo0.01.
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Melanocortins increased ROS generation in melanoma cells during
hypoxia
We next examined which of the POMC-derived peptides ele-
vated ROS generation in melanoma cells during hypoxia. To address
this question, cells were treated with one of the POMC-derived
peptides, α-, β-, and γ-MSH and ACTH (10 nM) for 24 h and then
incubated with CoCl2 (100 μM) for another 24 h before assessment
of ROS production with DCF-DA and Amplex red assays. As shown
in Fig. 5A, CoCl2-induced hypoxia stimulated DCF-DA signals in
melanoma cells and such induction was signiﬁcantly potentiated by
α-MSH, β-MSH, and ACTH but not γ-MSH. H2O2 generationwas also
Fig. 4. Excess ROS production by POMC gene delivery triggered the apoptotic process in B16-F10 melanoma cells during hypoxia. (A) Representative proﬁles of TUNEL and
DHE costaining in Ad-GFP- and Ad-POMC-treated melanoma. The apoptotic cells in melanoma were detected by TUNEL staining (green) and the cellular superoxide anion
(O2) is indicated with DHE (red). The cell nucleic acids were counterstained with DAPI (blue). Scale bar, 500 mm. (B) Measurement of intracellular ROS generation by DCF-DA
staining. (C) The extracellular H2O2 production was measured by Amplex red assay. (D) Flow cytometry analysis shows that blocking ROS generation with NAC (10 mM) could
rescue Ad-POMC-induced apoptosis in hypoxia. (E) The ratio of caspase-3 activity was measured by colorimetric caspase-3 activation assay. Data are expressed as means7SEM
from triplicate experiments. npo0.05, nnpo0.01. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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augmented by α-MSH, β-MSH, and ACTH peptides in the CoCl2
group (Fig. 5B). Our results suggested that POMC-derived peptides
(α-MSH, β-MSH, and ACTH) contributed to ROS generation in
melanoma during hypoxia.
ROS generation is mediated though α-MSH-induced Nox4 NADPH
oxidase upregulation
α-MSH was found to modulate the inhibitory effect of systemic
POMC delivery on the progression of melanoma [19]. We therefore
used α-MSH peptide to investigate the source of ROS generation in
cell apoptosis during hypoxia. Several endogenous enzymes,
including xanthine oxidase [28], mitochondrial enzymes [29],
cyclooxygenase [30], and NADPH oxidase [31], have been impli-
cated as sources of ROS generation in melanoma cells. To inves-
tigate which enzyme sources were involved in α-MSH-mediated
ROS generation during hypoxia, cells were treated with a pharma-
cological inhibitor of these enzymes 10 min before Amplex red
assay (Fig. 5C). None of the inhibitors affected basal H2O2 genera-
tion. The inhibitor of NADPH oxidase, DPI (0.1 μM), signiﬁcantly
abrogated α-MSH-induced ROS generation during hypoxia.
In contrast, inhibitors of xanthine oxidase (allopurinol, 50 μM)
and cyclooxygenase (indomethacin, 1 μM) did not affect the
stimulatory effect of α-MSH on H2O2 production, suggesting
NADPH oxidase was a major source of α-MSH-mediated ROS
generation in melanoma cells. We further investigated which of
the NADPH oxidase isoforms was involved in α-MSH-induced ROS
production. By using quantitative PCR and Western blot analysis of
NADPH oxidase isoforms (Nox1 to Nox4), we ﬁrst characterized
the Nox4 expression in B16-F10 melanoma cells (Supplementary
Fig. 3). Moreover, α-MSH enhanced Nox4 at the mRNA and protein
levels, whereas other NADPH oxidase isoforms (Nox1, Nox2, and
Nox3) remained undetected. Interestingly, α-MSH reversed the
inhibitory effect of hypoxia on Nox4 expression (Figs. 5D and E),
suggesting that the stimulatory effect of α-MSH on ROS generation
under hypoxic conditions was associated with an upregulation of
Nox4 expression.
Silencing Nox4 gene expression rescues α-MSH-induced apoptosis
during hypoxia
To investigate the role of Nox4 in α-MSH-induced apoptosis
during hypoxia, gene silencing of Nox4 with siRNA was performed
in B16-F10 melanoma cells. We ﬁrst veriﬁed that transfection of
Nox4 siRNA but not control siRNA signiﬁcantly attenuated the
mRNA and protein expression of Nox4 (Fig. 6A). Nox4 siRNA also
remarkably abolished the intracellular and extracellular H2O2
generation and inhibited the stimulatory effect of hypoxia on
ROS generation (Fig. 6B). Importantly, silencing of Nox4 gene
expression successfully alleviated α-MSH-induced apoptosis dur-
ing hypoxia (Fig. 6C). Moreover, immunostaining analysis revealed
that Nox4 staining has strong ﬂuorescence intensity in the
Ad-POMC-infected group and displayed a positive correlation with
TUNEL staining compared to the Ad-GFP-infected group (data not
shown). In summary, these results indicated that ROS derived from
Nox4 are involved in α-MSH-induced apoptosis in melanoma cells
during hypoxia.
Discussion
In this study we clariﬁed how Nox4-mediated ROS generation
was a key signaling pathway involved in cell apoptosis mediated
by POMC gene delivery in melanoma during hypoxic insults. Our
results provide further understanding of the tumor-suppressive
mechanisms of POMC for treatment of melanoma.
Fig. 5. Effect of POMC-derived peptides on ROS generation and association with an upregulation of Nox4 in hypoxia. (A, B) Clariﬁcation of POMC-derived peptide α-MSH,
β-MSH, ACTH, and γ-MSH (10 nM) capability to stimulate ROS generation by DCFH-DA and Amplex red assay. (C) The source of ROS generation. Analysis of ROS generation in
the absence and presence of DPI (0.1 mM), allopurinol (50 mM), and indomethacin (1 mM) after α-MSH stimulation by Amplex red assay. (D and E) The effect of α-MSH on
Nox4 gene and protein expression in the absence or presence CoCl2 (100 mM). Data are expressed as means7SEM from triplicate experiments. npo0.05, nnpo0.01.
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Tissue oxygenation is an important component of the tumor
microenvironment and contributes to melanocyte transformation
and melanoma development [32]. A hypoxic microenvironment is
a widespread phenomenon in tumors, especially in solid tumors [2].
Our data showed that POMC gene delivery rendered melanoma cells
more susceptible to hypoxia-induced damage. Several studies have
shown that accumulation of ROS was a major regulator to restrain
downstream PI3K/AKT signaling pathways and regressed the Bcl-2/
Bax ratio in melanoma [33,34]. Excess ROS generation can cause
apoptosis by triggering the opening of the mitochondrial perme-
ability transition pore and release of proapoptotic factors [11,12]. Our
data revealed that the overload of ROS generation was a main
operator for POMC-induced apoptosis in melanoma cells during
hypoxia. However, whether other sources of extracellular ROS gen-
eration from inﬁltrating neutrophils or phagocytes are involved in
apoptosis in tumor hypoxic regions requires further investigation.
Several sources of ROS including mitochondrial enzymes and
NADPH oxidase have been reported in melanoma cells [27].
A previous study found that the expression of the NADPH oxidase
components p22phox and Nox4 was required to transform and
promote malignant growth in human malignant melanoma cells
[31]. Yamaura et al. [35] also demonstrated that Nox4-mediated ROS
generation contributed to proliferation and transformation of the
melanoma phenotype by regulating G2–M cell cycle progression.
In addition, suppression of NADPH oxidase activity by targeting
subunits Rac1 and p47phox was found to promote melanogenic
differentiation in B16 melanoma cells [36]. We recently demon-
strated that the NADPH oxidase isoform Nox4 was a major source of
ROS generation upon α-MSH stimulation. Nox4 acts as a feedback
mechanism to control melanogenic differentiation by suppressing
microphthalmia-associated transcription factor (MITF)-mediated
tyrosinase mRNA expression [24]. Here, our data show that the
POMC-induced apoptosis under hypoxic conditions was mediated
by an upregulation of Nox4. The POMC-derived peptide α-MSH was
found to stimulate ROS generation during hypoxia and this con-
tributes to inducing apoptosis in POMC gene therapy in melanoma.
Suppressing Nox4 expression by siRNA or scavenging ROS accumu-
lation by NAC reduced apoptosis in POMC gene delivery or α-MSH-
treated melanoma cells, pinpointing the role of Nox4-derived ROS in
POMC-induced cell apoptosis. However, the precise molecular
mechanism of how Nox4-derived ROS induced apoptosis by POMC
gene delivery in melanoma cells remained unclear.
The melanocortin 1 receptor (MC1R) is one of the melanocortin
receptors that has been shown to have a high binding afﬁnity for its
ligand α-MSH, and MC1R is implicated in several physiological
functions including pigmentation and inﬂammation [37]. In all of
these regulatory signaling pathways it has been shown that the
secondary messenger cAMP-triggered downstream effector mole-
cules protein kinase A (PKA) and cAMP-responsive element binding
protein 1 transcription factor promote MITF in melanogenic differ-
entiation [38]. Our recent study also demonstrated that upregula-
tion of Nox4 and ROS generation occurred through the MC1R/PKA/
MITF pathway in melanoma cells [24]. In the present study, our
data show that POMC gene delivery triggered ROS production,
possibly through α-MSH, β-MSH, and ACTH peptides, which have
high binding afﬁnity to MC1R. Therefore, POMC-derived peptide
α-MSH, β-MSH, and ACTH induction of Nox4-derived ROS is
probably driven by the MC1R/cAMP/PKA/MITF pathway. However,
the precise molecular mechanisms still need further evaluation.
In summary, we showed that Nox4-mediated ROS generation
was a major cause of apoptosis induced by POMC-derived peptides
during hypoxic insult. These observations provide a better under-
standing at the molecular level of the hypoxic conditions in the
tumor environment. Our results provide an understanding of
tumor-suppressive mechanisms of POMC in mouse B16-F10 mel-
anoma cells, which may facilitate a novel therapy for melanoma
control.
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